Annual EBITDA
-$11.87 M
+$6.17 M+34.21%
December 1, 2023
Summary
- As of February 25, 2025, PVLA annual EBITDA is -$11.87 million, with the most recent change of +$6.17 million (+34.21%) on December 1, 2023.
- During the last 3 years, PVLA annual EBITDA has risen by +$6.17 million (+34.21%).
Performance
PVLA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$1.73 M
+$2.40 M+58.12%
March 1, 2024
Summary
- As of February 25, 2025, PVLA quarterly EBITDA is -$1.73 million, with the most recent change of +$2.40 million (+58.12%) on March 1, 2024.
- Over the past year, PVLA quarterly EBITDA has increased by +$2.40 million (+58.12%).
Performance
PVLA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$1.73 M
+$2.40 M+58.12%
March 1, 2024
Summary
- As of February 25, 2025, PVLA TTM EBITDA is -$1.73 million, with the most recent change of +$2.40 million (+58.12%) on March 1, 2024.
- Over the past year, PVLA TTM EBITDA has increased by +$2.40 million (+58.12%).
Performance
PVLA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PVLA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +34.2% | +58.1% | +58.1% |
| 3 y3 years | +34.2% | +58.1% | +58.1% |
| 5 y5 years | +34.2% | +58.1% | +58.1% |
PVLA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +52.0% | at high | +138.8% | at high | +138.8% |
| 5 y | 5-year | at high | +52.0% | at high | +138.8% | at high | +138.8% |
| alltime | all time | at high | +52.0% | at high | +138.8% | at high | +138.8% |
Palvella Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | -$1.73 M(-58.1%) | -$1.73 M(-58.1%) |
| Dec 2023 | -$11.87 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$4.13 M | -$4.13 M |
| Dec 2022 | -$18.04 M | - | - |
FAQ
- What is Palvella Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Palvella Therapeutics?
- What is Palvella Therapeutics annual EBITDA year-on-year change?
- What is Palvella Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Palvella Therapeutics?
- What is Palvella Therapeutics quarterly EBITDA year-on-year change?
- What is Palvella Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Palvella Therapeutics?
- What is Palvella Therapeutics TTM EBITDA year-on-year change?
What is Palvella Therapeutics annual EBITDA?
The current annual EBITDA of PVLA is -$11.87 M
What is the all time high annual EBITDA for Palvella Therapeutics?
Palvella Therapeutics all-time high annual EBITDA is -$11.87 M
What is Palvella Therapeutics annual EBITDA year-on-year change?
Over the past year, PVLA annual EBITDA has changed by +$6.17 M (+34.21%)
What is Palvella Therapeutics quarterly EBITDA?
The current quarterly EBITDA of PVLA is -$1.73 M
What is the all time high quarterly EBITDA for Palvella Therapeutics?
Palvella Therapeutics all-time high quarterly EBITDA is -$1.73 M
What is Palvella Therapeutics quarterly EBITDA year-on-year change?
Over the past year, PVLA quarterly EBITDA has changed by +$2.40 M (+58.12%)
What is Palvella Therapeutics TTM EBITDA?
The current TTM EBITDA of PVLA is -$1.73 M
What is the all time high TTM EBITDA for Palvella Therapeutics?
Palvella Therapeutics all-time high TTM EBITDA is -$1.73 M
What is Palvella Therapeutics TTM EBITDA year-on-year change?
Over the past year, PVLA TTM EBITDA has changed by +$2.40 M (+58.12%)